id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
584041,746335fc-d173-4892-87ef-6c4d28069226,Q1,GILBERT'S LLP,67876,MYLAN LABORATORIES INC,2008,first_quarter,PHA,Enforcement and possible reform of the legislation and regulations relating to drug approval,"Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE",90000,,0,0,2008-03-16T14:52:31-04:00
584053,42229c61-3956-46d2-ad4d-98a7f7ede2d5,Q1,FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC),86196,PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA),2008,first_quarter,PHA,Monitor legislative developments in health care,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2008-03-16T14:52:31-04:00
584133,3dfd6614-1f8a-41dd-8dd4-4a5e8ea10275,Q1,"CUBIST PHARMACEUTICALS, INC.",40026226,CUBIST PHARMACEUTICALS,2008,first_quarter,PHA,"Medical Research
Prescription drug/Federal Drug Admin/Center for Disease Control/Health and Human Service issues
Antibiotic Resistance issues H.R. 1174, Healthy Hospitals Act
H.R. 3697, Strategies to Address Antimicrobial Resistance Act
H.R. 4352, Antimicrobial Task Force in public schools
H.R. 4451, MRSA Research and Study Act
S. 2278, Community and Healthcare Associated Infections Reduction Act
S. 2313, Strategies to Address Antimicrobial Resistance Act
S. 2525, MRSA Infection Prevention and Patient Protection Act
S. 2526, Worker Infection Protection Act","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",,131329,0,0,2008-03-16T14:52:31-04:00
584208,88060b61-fcdb-4ca4-aea7-7a2e47d7d4ee,Q3,FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC),86196,PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA),2008,third_quarter,PHA,Monitor legislative developments in health care,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2008-03-23T11:31:28-04:00
584243,f18cb41d-e309-4dd7-8753-77af83ceb53f,Q2,FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC),86196,PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA),2008,second_quarter,PHA,Monitor legislative developments in health care,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2008-03-23T11:31:28-04:00
584306,2abcaf92-e25a-4119-9f86-4f49903f4bd4,Q4,FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC),86196,PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA),2008,fourth_quarter,PHA,Monitor legislative developments in health care,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2008-03-23T11:31:28-04:00
584462,dbad19b4-2f6c-41e7-b874-3d61db0a70b9,Q1,AMERICAN CAPITOL GROUP,305852,DISPENSING SOLUTIONS INC,2008,first_quarter,PHA,"Drug Importation, Phrmacy, Counterfiet Drugs",,10000,,0,0,2008-03-27T15:26:05-04:00
584495,33a4d27d-fd41-49dc-9bd3-8b1f5b6802d8,Q1,"MAYBERRY & ASSOCIATES, LLC",51968,HEALTHCARE COMPLIANCE PACKAGING COUNCIL,2008,first_quarter,PHA,Pharmaceutical regimen compliance.,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2008-03-31T08:37:18-04:00
584501,45a8246b-d13e-4a9a-a033-40da7c118f7c,Q1,"MAYBERRY & ASSOCIATES, LLC",51968,PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION,2008,first_quarter,PHA,"Food, Drug and Cosmetic Act.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2008-03-31T09:07:23-04:00
584531,7f1c5857-b976-4b2b-b419-16e623cd0fd8,3A,"RUBICON ADVISORS, LLC",315091,TEVA PHARMACEUTICALS USA,2008,third_quarter,PHA,"Patent Settlements H.R. 1432 S. 316, Generic Biologics S. 1695 H.R. 5629, Physician Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100",,105000,,0,0,2008-03-31T09:38:35-04:00
584533,8eb52607-8398-47aa-ac2b-6728cf93f6f3,Q4,"RUBICON ADVISORS, LLC",315091,TEVA PHARMACEUTICALS USA,2008,fourth_quarter,PHA,"Patent Settlements H.R. 1432 S. 316, Generic Biologics S. 1695 H.R. 5629, Physician Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100",,105000,,0,0,2008-03-31T09:38:35-04:00
584738,57979701-a29e-48a1-9e02-7755fa32357f,Q1,GO DADDY.COM,303553,GO DADDY COM,2008,first_quarter,PHA,S.980 Controlled Substances Act,"Federal Communications Commission (FCC),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Telecommunications & Information Administration (NTIA),SENATE,State, Dept of (DOS)",,143500,0,0,2008-04-01T15:03:58-04:00
584821,60bcf8a5-b712-46df-a230-b0189cdde21a,Q1,INDEPENDENT PHARMACY COOPERATIVE,313098,INDEPENDENT PHARMACY COOPERATIVE,2008,first_quarter,PHA,"S. 195 and H.R. 3140 Fair Medicaid Reimbursement (AMP), S.1954 and H.R. 1474 (Medicare Part D Prompt Payment)","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",,10000,0,0,2008-04-02T10:41:06-04:00
585212,789a17ac-303e-41dc-b8c4-3031278c6cc7,Q1,KIRKLAND & ELLIS LLP,21745,TEVA PHARMACEUTICALS USA,2008,first_quarter,PHA,House and Senate legislation on biologic medicines.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2008-04-04T10:57:42-04:00
585488,372e1532-7a69-447c-9025-de0c0d8d9b9e,Q1,MARSHALL BRACHMAN,6848,STEWART JACKSON PHARMACAL,2008,first_quarter,PHA,Senate HELP Committee and House Energy and Commerce Committee: monitor FDA legislation related to regulation of pharmaceutical manufacturing,"HOUSE OF REPRESENTATIVES,SENATE",6000,,0,0,2008-04-06T19:18:00-04:00
585517,f10a48b2-9536-4c5a-b328-ccbeb0161759,Q1,"DUTKO WORLDWIDE, LLC",12868,IBIS BIOSCIENCES,2008,first_quarter,PHA,Counsel and advise regarding attempts to secure federal procurement contracts for a biosensor device.,"Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",,,0,0,2008-04-07T09:48:46-04:00
585680,5ce78fac-c78c-4abe-a19d-e3c5bfefacbd,Q1,INTERNATIONAL COMMERCE DEVELOPMENT CORP,286278,AMPHASTAR PHARMACEUTICALS INC,2008,first_quarter,PHA,Seeking general pharmaceuticals approvals for client from the FDA and EPA.,"Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",170000,,0,0,2008-04-07T13:18:22-04:00
585771,b055fbb0-4886-40e5-80bb-f6e21a020dfc,1T,VAN FLEET ASSOCIATES,39781,AMERICAN COUNCIL ON REGULATORY COMPLIANCE,2008,first_quarter,PHA,Over the counter salesof productsthat contain ephedrine and psedoephedrine.,"Drug Enforcement Administration (DEA),Food & Drug Administration (FDA)",,,0,1,2008-04-07T15:00:08-04:00
585812,9aed0cfd-114e-41d3-bbd8-440b23c6a67b,Q1,VAN FLEET ASSOCIATES,39781,KIRK PHARMACEUTICALS,2008,first_quarter,PHA,FDA and DEA regulation pertaining to over the counter drug sales.,"Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2008-04-07T16:07:49-04:00
585934,b85442be-d5c5-4aef-87e4-d8ebb6efc046,Q1,"DUTKO WORLDWIDE, LLC",12868,MEDIMPACT HEALTHCARE SYSTEMS,2008,first_quarter,PHA,Work with CMS on the role of PBM's in delivering the Medicare Part D benefit and related operational issues.,"Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2008-04-08T10:13:11-04:00
585949,6489bb7a-1985-4610-a045-bcaa0ddb07ba,Q1,"DUTKO WORLDWIDE, LLC",12868,NEWAYS INTERNATIONAL,2008,first_quarter,PHA,"Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly S. 762.","Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2008-04-08T10:29:25-04:00
586288,73800857-a950-433e-a92a-be30543b4efb,Q1,"CYBER SECURITY RESEARCH CONSULTANTS, LLC",91694,PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION,2008,first_quarter,PHA,Monitoring Dorgan/Snowe drug re-importation from Canada,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2008-04-08T18:58:36-04:00
586333,49ad7797-e62f-407c-8960-15686d0915bc,Q1,BROYDRICK & ASSOCIATES,7268,BARR LABORATORIES,2008,first_quarter,PHA,"Patent reform, Generic Biologies",,,,0,0,2008-04-09T09:33:27-04:00
587014,7ca20ec0-4221-4f07-90ea-19cc33a6b865,Q1,"GREENLEE PARTNERS, LLC",79995,PFIZER,2008,first_quarter,PHA,pharmaceutical bills,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2008-04-10T11:12:07-04:00
587032,7e6c201a-9826-474b-9a18-78e130f1a07a,1A,"DUTKO WORLDWIDE, LLC",12868,MEDIMPACT HEALTHCARE SYSTEMS,2008,first_quarter,PHA,Work with CMS on the role of PBM's in delivering the Medicare Part D benefit and related operational issues.,"Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2008-04-10T11:25:25-04:00
587130,27379b88-bbcc-4334-90c9-58d122c20da7,1A,"DUTKO WORLDWIDE, LLC",12868,NEWAYS INTERNATIONAL,2008,first_quarter,PHA,"Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly S. 762.","Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2008-04-10T12:51:30-04:00
587244,c8a9cf08-1092-4787-8482-f876a313a230,Q1,VENABLE LLP,39941,ENDO PHARMACEUTICALS INC,2008,first_quarter,PHA,General issues affecting the pharmaceutical industry.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2008-04-10T14:40:40-04:00
587561,08937eb9-102e-4f46-bc5a-47fc66d30735,Q1,MEREDITH MCGEHEE,79858,INTERNATIONAL AIDS VACCINE INITIATIVE,2008,first_quarter,PHA,funding for programs to develop AIDS vaccine targeted toward the developing world; research and development programs aimed at the AIDS epidemic; tax issues affecting AIDS vaccine programs; patent issues related to vaccine development; reauthorization of PEPFAR; appropriation for IAVI,,21600,,0,0,2008-04-11T10:33:46-04:00
587701,7b0090cd-3ed0-41d8-92b5-cf666af54929,Q1,"THE OB-C GROUP, LLC",29802,ELI LILLY,2008,first_quarter,PHA,"S 3, Medicare Prescription Drug Price Negotiation Act of 2007: Medicare program.
HR 4, Medicare Prescription Drug Price Negotiation Act of 2007: Medicare program.
HR 5629, Pathway for Biosimilars Act: biologics.
S 1695, Biologics Price Competition and Innovation Act of 2007: biologics.","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2008-04-11T12:00:05-04:00
588099,d4ff6d00-cd77-4a94-9ea8-dc9e55a1d120,Q1,AMERICAN SOCIETY OF CONSULTANT PHARMACISTS,3446,AMERICAN SOCIETY OF CONSULTANT PHARMACISTS,2008,first_quarter,PHA,Increasing number of pharmacists who specialize in geriatric pharmacy,"Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,SENATE",,40000,0,0,2008-04-11T19:08:32-04:00
588163,ff053ce3-ae80-4ca2-836f-517819e8892c,Q1,"RUBICON ADVISORS, LLC",315091,AMERICAN SOCIETY OF INTERVENTIONAL PAIN PHYSICIANS,2008,first_quarter,PHA,"Healthcare:  centers for Medicare & Medicaid Services (CMS), Reimbursements",,30000,,0,0,2008-04-13T11:08:06-04:00
588164,4b8e70fa-efd9-4104-9afc-6f7e89cbf180,Q1,"RUBICON ADVISORS, LLC",315091,HEYL CHEMISCH-PHARMAZEUTISCHE FABRIK GMBH AND CO KG,2008,first_quarter,PHA,"Healthcare:  Pharmaceuticals, Bioshield",,22500,,0,0,2008-04-13T11:12:08-04:00
588165,192d10de-9c16-42cc-99e8-3ce4e8effab2,Q1,"RUBICON ADVISORS, LLC",315091,INSMED INCORPORATED,2008,first_quarter,PHA,Pharmaceutical Issues,,22500,,0,0,2008-04-13T11:14:10-04:00
588166,f6f97f40-7020-4b2f-b814-5d069a62a9e2,Q1,"RUBICON ADVISORS, LLC",315091,TEVA PHARMACEUTICALS USA,2008,first_quarter,PHA,"Healthcare:  Pharmaceuticals, Prescription Drug User Fee",,90000,,0,0,2008-04-13T11:16:12-04:00
588167,3cd46413-0f98-416e-b895-6bd5568d8b6b,Q1,"RUBICON ADVISORS, LLC",315091,WATSON PHARMACEUTICALS INC,2008,first_quarter,PHA,"Healthcare:  Pharmaceuticals, Prescription Drug User Fee",,102000,,0,0,2008-04-13T11:20:15-04:00
588168,5b132b09-2ca7-4c70-b420-1a92d0a205eb,Q1,"RUBICON ADVISORS, LLC",315091,FLEMING PHARMACEUTICALS,2008,first_quarter,PHA,"Healthcare:  Pharmaceuticals, Bioshield",,30000,,0,0,2008-04-13T11:23:17-04:00
588169,5b7cd131-a6f3-42b4-a225-501c3d44a951,Q1,"RUBICON ADVISORS, LLC",315091,GILEAD SCIENCES,2008,first_quarter,PHA,Healthcare:  Pharmaceuticals,,75000,,0,0,2008-04-13T11:25:19-04:00
588312,62011b73-0493-4497-90a6-9d8b780b6d52,Q1,ACADEMY OF MANAGED CARE PHARMACY,48793,ACADEMY OF MANAGED CARE PHARMACY,2008,first_quarter,PHA,"Establishing a regulatory pathway for Food and Drug Administration approval of follow-on biologic products, Electronic prescribing of controlled substances, Regulation of online pharmacies, Importation of prescription drugs.","HOUSE OF REPRESENTATIVES,SENATE",,46688,0,0,2008-04-14T09:38:20-04:00
588339,82bb9def-4a99-4cd0-ad4a-9c812c54a482,Q1,"VORYS, SATER, SEYMOUR AND PEASE LLP",40236,SOLVAY PHARMACEUTICALS INC,2008,first_quarter,PHA,Implementation of national strategy to prepare for pandemic influenza.,,10000,,0,0,2008-04-14T10:28:21-04:00
588444,0ac47abd-b8f8-4bf7-a54b-be89a8b765ac,Q1,POLICY ADVOCATES,72018,PHOENIX CAPITAL MANAGEMENT LLC,2008,first_quarter,PHA,"S.980: Online Pharmacy Consumer Protection Act of 2007 - Track and monitor.
S.596: Safe Internet Pharmacy Act of 2007 - Track and monitor.","HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2008-04-14T11:16:46-04:00
589746,ade193b7-9dea-403c-8c81-eb95ee5292eb,Q1,"TIMMONS AND COMPANY, INC.",38164,TEVA PHARMACEUTICALS USA INC,2008,first_quarter,PHA,"S. 28 - To amend title XVIII of the Social Security Act to require the use of generic drugs under the Medicare part D prescription drug program when available unless the brand name drug is determined to be medically necessary.
S. 1505 - Affordable Biologics for Consumers Act. S. 1695 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes.
S. 242 - Pharmaceutical Market Access and Drug Safety Act of 2007.
S. 251 - Pharmaceutical Market Access Act of 2007.
S. 1082 - Prescription Drug User Fee Amendments of 2007.
H.R. 2900 - Food and Drug Administration Amendments Act of 2007.
H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act.
H.R. 1038 - Access to Life-Saving Medicine Act.
H.R. 5629 - Pathway for Biosimilars Act","HOUSE OF REPRESENTATIVES,SENATE",100000,,0,0,2008-04-15T12:03:19-04:00
589786,8bc34aa6-1b9c-4529-b1a6-9b834e611751,Q4,"RUBICON ADVISORS, LLC",315091,INSMED INCORPORATED,2008,fourth_quarter,PHA,Generic Biologics S. 1695,,22500,,0,0,2008-04-15T12:07:25-04:00
590185,b9fbf660-cad4-4d72-a614-2ce9319ff745,Q1,BUCHANAN INGERSOLL & ROONEY PC,55291,SHIRE PHARMACEUTICALS INC,2008,first_quarter,PHA,Education and policy issues.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2008-04-15T14:57:28-04:00
590207,6fd3e2b4-821a-4120-ada5-8981cd0b686f,Q1,POLICY DIRECTIONS INC.,31747,ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ),2008,first_quarter,PHA,"Antibiotics in animal foods
Drug approvals 
S. 549/HR 962, all titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine.

S. 2313/HR3697, all titles, to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA.

HR 3610 to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling.

Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act.

Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds.","Agriculture, Dept of (USDA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2008-04-15T15:04:11-04:00
590516,3fce0cbf-faea-4c9a-aae5-66f38b87a529,Q1,"APTIV, PLC",49054,APTIV PLC,2008,first_quarter,PHA,"Implementation of Medicare prescription drug program
Accessibility of generic drugs
e-prescriptions
Medical IT",,,190000,0,0,2008-04-15T16:35:38-04:00
590634,e2c449aa-50dd-4604-af94-392cce516af4,Q1,CONSULTANTS COLLABORATIVE -- MATTHEW R. SIMMONS,311713,NATIONAL COALITION OF PHARMACEUTICAL DISTRIBUTORS,2008,first_quarter,PHA,Pharmaceutical Pedigree Related Policy/Legislation,"HOUSE OF REPRESENTATIVES,SENATE,Small Business Administration (SBA)",30000,,0,0,2008-04-15T17:15:34-04:00
591268,2f94cd4b-341f-4704-979a-e89f174ee62c,Q1,NATIONAL COMMUNITY PHARMACISTS ASSOCIATION,27478,NATIONAL COMMUNITY PHARMACISTS ASSOCIATION,2008,first_quarter,PHA,"I.   HR 971, the ""Community Pharmacy Fairness Act of 2007""; S. 2161, the ""Community Pharmacy Fairness Act of 2007""; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the ""Medicare Prescription Drug Price Negotiation Act of 2007""; potential language not included in S. 2499, the ""Medicare, Medicaid and SCHIP Extension Act of 2007"" re e-prescribing; HR 1474, the ""Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier;

II.       and also HR 3140, ""Saving Our Community Pharmacies Act of 2007""; S. 1951, the ""Fair Medicaid Drug Payment Act of 2007""; S. 1954, the ""Pharmacy Access Improvement (PhAIm) Act of 2007""; HR 3700, the ""Fair Medicaid Drug Payment Act of 2007""; Sec. 7002(b) of HR 2006 and PL 110-28, ""Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program"", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.",,,120000,0,0,2008-04-16T10:49:01-04:00
591411,a6f4306b-d732-4153-a8b6-3c24267c0d51,1A,FAMILY RESEARCH COUNCIL,14110,FAMILY RESEARCH COUNCIL,2008,first_quarter,PHA,"S. 1082
Prescription Drug User Fee Amendments of 2007
Use drug fees toward expediting drug development, reviewing drug applications and drug safety","HOUSE OF REPRESENTATIVES,SENATE",,30000,0,0,2008-04-16T11:20:47-04:00
591637,9142b91f-42dc-4610-a595-371866a3e3aa,Q1,KNIGHT CAPITOL CONSULTANTS,40036301,GENZYME CORPORATION,2008,first_quarter,PHA,"S.1695 : A bill to amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2008-04-16T11:54:11-04:00
591706,125abcf5-b513-43df-b5c4-62c818e8fe3b,Q1,CAPITOL HILL CONSULTING GROUP,72053,ASTELLAS PHARMA US,2008,first_quarter,PHA,"Pharmaceutical and life sciences, including but not limited to: The Federal Food, Drug and Cosmetic Act; the Hatchwaxman Act; drug imporation; and drug safety","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2008-04-16T12:01:39-04:00
591828,45dfead4-faff-400c-b294-89fcfeec0c26,Q1,"PODESTA GROUP, INC.",31680,BRISTOL-MYERS SQUIBB,2008,first_quarter,PHA,"H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics
H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions
H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics
S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics
S. 2029, Physician Payments Sunshine Act of 2007 
S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions
S. 623, Access to Life-Saving Medicine Act, follow-on biologics
Drug importation","Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2008-04-16T12:27:10-04:00
592116,e417c5b6-7291-4329-8cf5-db700a47b5f1,Q1,CAPITOL HILL CONSULTING GROUP,72053,NOVARTIS CORPORATION,2008,first_quarter,PHA,"Pharmaceutical and life sciences issues, including but not limited to: The Federal Food, Drug and Cosmetic Act; the Hatch-Waxman Act; drug safety","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2008-04-16T13:49:16-04:00
592141,56782d47-deed-47d4-8196-a82ce3090f46,Q1,PRICEWATERHOUSECOOPERS,10764,SCHERING-PLOUGH CORPORATION,2008,first_quarter,PHA,General issues affecting pharmaceutical companies,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2008-04-16T13:54:32-04:00
592169,3c112bdb-defc-43af-8904-d1962c233b96,Q1,UNIVERSITY OF PITTSBURGH MEDICAL CENTER,32065,UNIVERSITY OF PITTSBURGH MEDICAL CENTER,2008,first_quarter,PHA,Issues related to the cost of prescription pharmaceuticals and the impact of that cost on hospitals and health care providers.,"Air Force, Dept of,Army, Dept of (Other),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,260000,0,0,2008-04-16T13:59:27-04:00
592311,d0ec3150-1b3e-4519-9ff3-199f6faf1590,Q1,CAPITOL HILL CONSULTING GROUP,72053,PURDUE PHARMA LLP,2008,first_quarter,PHA,"general pharmaceutical issues, including but not limited to: The Federal Food, Drug and Cosmetic Act; the Controlled Drug Substances Act; drug imporation; and drug safety","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2008-04-16T14:29:39-04:00
592452,4d1819a6-0e6f-4c90-9a52-05d9a35560f9,Q1,LATHAM & WATKINS LLP,22201,AMPHASTAR PHARMACEUTICALS,2008,first_quarter,PHA,"Congressional oversight of the Food and Drug Administration and Environmental Protection Agency
EPA rulemaking on CFC propellants","Environmental Protection Agency (EPA),Food & Drug Administration (FDA)",,,0,0,2008-04-16T14:52:34-04:00
592509,69efd1d8-6547-4ef0-84c5-da3fdeaf690c,Q1,AMYLIN PHARMACEUTICALS,308536,AMYLIN PHARMACEUTICALS,2008,first_quarter,PHA,"HR 1038, Access to Life-Saving Medicines Act, follow-on biologics
HR 1561, Enhancing Drug Safety and Innovation Act of 2007
HR 1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics
S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics
S. 2029, Physician Payments Sunshine Act of 2007
S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions
S. 623, Access to Life Saving Medicine Act, follow-on biologics
Drug Importation","Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,198000,0,0,2008-04-16T15:04:08-04:00
592732,cfea26c6-c582-46cb-8be8-1fad9da3c07e,Q1,"ASSOCIATION OF NATIONAL ADVERTISERS, INC.",4653,"ASSOCIATION OF NATIONAL ADVERTISERS, INC.",2008,first_quarter,PHA,"S. 2311 and H.R. 4083, Non-Prescription Drug Modernization Act of 2007, provisions to grant the FDA authority over advertising for over-the-counter drugs","Federal Communications Commission (FCC),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE",,250000,0,0,2008-04-16T15:54:33-04:00
592762,b46cc7b8-6c6b-42ea-92df-ba30ab7f2b04,Q1,"POLICY IMPACT COMMUNICATIONS, INC.",31758,STRATEGIC APPLICATIONS INTERNATIONAL LLC,2008,first_quarter,PHA,Development of legislation to restore Medicaid benefits for mentally ill offenders.,,15000,,0,0,2008-04-16T15:57:12-04:00
592949,8702ace4-4def-485b-9392-4237245a1ca8,Q1,UPS (UNITED PARCEL SERVICE),39223,UPS (UNITED PARCEL SERVICE),2008,first_quarter,PHA,Pedigree - pharmaceutical distribution,"Commerce, Dept of (DOC),Federal Aviation Administration (FAA),Government Accountability Office (GAO),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT),Transportation Security Administration (TSA),Treasury, Dept of,U.S. Customs & Border Protection,U.S. Trade Representative (USTR),White House Office",,616000,0,0,2008-04-16T16:35:27-04:00
593338,386a6699-cea6-436e-a602-cfa44874d4bb,Q1,AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS,3457,AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS,2008,first_quarter,PHA,"Health Services and Resources Administration 340 B drug pricing program; proposed guidance on definition of patient, contract pharmacy and participation by children's hospitals.  HR 3580, Food and Drug Administration Amendments Act of 2007, titles 8 and 9, all provisins. S.901.  Reauthorization of National Health Service Corps.  Provisions relating to loan forgiveness programs.  Funding for Food and Drug Administration.  HR 1956, Patient Protection and Innovative Biologic Medicines Act of 2007 and HR 1038, Access to Life Saving Medicine Act, HR 5629, Pathway for Biosimilars Act, provisions dealing with interchangability.   HR 5491, Pharmacy Technician Training and Registration Act of 2008, all provisions.  Proposal by FDA for a behind the counter drug category (public meeting and comments).  Distribution of patient information and medication guides.  Pharmacologic class in patient information.  Proposal to transition Mevacor from prescription to over the counter status.","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,200276,0,0,2008-04-16T18:17:20-04:00
593447,4485a56e-9bba-4643-8d19-9355e2484ac2,Q1,MCDERMOTT WILL & SCHULTE LLP,24338,RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION,2008,first_quarter,PHA,Amendments to Section 340(b) of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program.,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",70000,,0,0,2008-04-16T20:01:00-04:00
593451,fe217b6d-04ae-4d3b-97ce-9ab9c11ec1bc,Q1,"PODESTA GROUP, INC.",31680,CUBIST PHARMACEUTICALS INC,2008,first_quarter,PHA,"Medical Research
Prescription drug/Federal Drug Admin/Center for Disease Control/Health and Human Service issues
Antibiotic Resistance issues H. R. 1174, Healthy Hospitals Act
H. R. 3697, Strategies to Address Antimicrobial Resistance Act
H. R. 4352, Antimicrobial Task Force in public schools
H. R. 4451, MRSA Research and Study Act
S. 2278, Community and Healthcare Associated Infections Reduction Act
S. 2313, Strategies to Address Antimicrobial Resistance Act
S. 2525, MRSA Infection Prevention and Patient Protection Act
S. 2526, Worker Infection Protection Act","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",40000,,0,0,2008-04-16T20:01:19-04:00
593794,67cf59e1-9252-47f2-b45a-32124abf1d1f,1A,KIRKLAND & ELLIS LLP,21745,TEVA PHARMACEUTICALS USA,2008,first_quarter,PHA,House and Senate legislation on biologic medicines.,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2008-04-17T09:58:52-04:00
594353,bddd9c91-4a7c-49bc-8ad7-252dd49cb796,Q1,THE ACCORD GROUP,42785,CITIZENS FOR SUN PROTECTION,2008,first_quarter,PHA,Final promulgation of sunscreen monograph,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2008-04-17T11:24:51-04:00
594541,f01af9b1-1a45-4d3b-8d55-85758c65086e,Q1,THE ACCORD GROUP,42785,CIBA SPECIALTY CHEMICALS CORP,2008,first_quarter,PHA,Sunscreen addititves,"Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE,U.S. International Trade Commission (ITC)",37500,,0,0,2008-04-17T11:59:33-04:00
594555,2152fe6d-a881-4d75-991a-759ffac4d0d1,Q1,STANTON PARK GROUP,83717,BARR LABORATORIES,2008,first_quarter,PHA,"Generic Biologics (HR 1956, S. 1695, HR 1038, S 623, HR 5629); FDA REform (HR 2900, S 1082) office of Generic Drugs funding in Agrigultural Approps. (HR 3161, S 1859)","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2008-04-17T12:03:02-04:00
594664,04a18839-9d60-43e3-a0b9-5a71b472fd1f,Q1,"STUNTZ DAVIS & STAFFIER, P.C.",37141,PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA,2008,first_quarter,PHA,Drug safety issues.  Pharmaceutical user fees.  Foreign drug inspections.  Drug reimportation.,,10000,,0,0,2008-04-17T12:29:21-04:00
594907,3c9551d3-c9e9-4a6c-9ba9-1d756746d3de,Q1,ELI LILLY AND COMPANY,13392,ELI LILLY AND COMPANY,2008,first_quarter,PHA,DTC (S 2445),"Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Security Agency (NSA),Natl Security Council (NSC),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR)",,2895000,0,0,2008-04-17T13:27:11-04:00
595392,63095fac-27d6-4a69-b367-4d06e4b65e44,Q1,NOVO NORDISK INC.,284790,NOVO NORDISK INC.,2008,first_quarter,PHA,"H.R. 3610, Foreign Facility FDA Inspection User Fees; H.R. 1585, National Defense Authorization (portions relating to Tricare); protecting patient access in S. 877, Controlling the Abuse of Prescriptions Act; S. 2029, Physician Payments Sunshine Act of 2007; S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Patent & Trademark Office (PTO),SENATE",,330000,0,0,2008-04-17T14:43:32-04:00
595570,c96b881c-aa16-4669-8e69-5aeac5b93d87,Q1,AMERICAN COLLEGE OF CLINICAL PHARMACY,57258,AMERICAN COLLEGE OF CLINICAL PHARMACY,2008,first_quarter,PHA,Coverage for direct patient care medication management services of qualified pharmacists Medicare Part B.,"Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,55950,0,0,2008-04-17T15:09:47-04:00
595608,b756a007-9572-4efd-8fc1-77676946ea12,Q1,GOODWIN PROCTER LLP,79756,TEVA PHARMACEUTICALS USA INC,2008,first_quarter,PHA,S.623 ACCESS TO LIFE SAVING MEDICINES ACT; H.R.1038 ACCESS TO LIFE SAVING MEDICINES ACT; S.1505 AFFORDABLE BIOLOGICS FOR CONSUMERS; S.1695 BIOLOGICS PRICE COMPETITION AND INNOVATION ACT OF 2007; H.R. 1956 THE PATIENT PROTECTION AND INNOVATIVE BIOLOGIC MEDICINE ACT; S.1145 PATENT REFORM ACT OF 2007; H.R. 1908 PATENT REFORM ACT OF 2007 (ALL PROVISIONS FOR ALL BILLS),"HOUSE OF REPRESENTATIVES,SENATE",150000,,0,0,2008-04-17T15:18:05-04:00
595659,e1a1e551-b20d-4502-97f8-21de63361427,Q1,JENNINGS POLICY STRATEGIES,64656,GENERAL MOTORS CORP,2008,first_quarter,PHA,"-Advocated for cost containment policies including generic access and comparative effectiveness (including H.R. 1038 and S. 623) and policies that promote competition in the pharmaceutical marketplace
-Advocated for policies promoting broad health coverage reform, including support for initiatives designed to reform retiree health liabilities that undermine competitiveness and policies related to Medicare coverage of end-stage renal disease services","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2008-04-17T15:24:29-04:00
596115,f279eac5-af20-407b-b53d-aa53568c539d,Q1,GENZYME CORPORATION,16054,GENZYME CORPORATION,2008,first_quarter,PHA,"H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics
H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics
H.R. 5629, Pathway for Biosimilars Act S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics
S. 1695, Biologics Price Competition and Innovation Act of 2007, Follow-on Biologics
S. 2029, Physician Payments Sunshine Act of 2007
S. 623, Access to Life-Saving Medicine Act, follow-on biologics
Neglected Disease Issues
Issues related to Drug Safety, Generic Biologics & Drug Approvals
H.R. 380, ""Pharmaceutical Market Access and Drug Safety act of 2007"" - Importation.
S.251, Pharmaceutical Market Access & Drug Safety Act of 2007"" - Importation.
S.242, ""Pharmaceutical Market Access & Drug Safety Act of 2007""
H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,640000,0,0,2008-04-17T16:17:26-04:00
596361,8011293d-0a95-48af-98a0-c0608a15467d,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,INTL ACADEMY OF COMPOUNDING PHARMACISTS,2008,first_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2008-04-17T16:55:31-04:00
596466,fe9012ac-8da4-401e-b4d5-07fd81ca551e,Q1,"AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES",2321,AMERICAN FEDERATION OF STATE COUNTY AND MUNICIPAL EMPLOYEES,2008,first_quarter,PHA,"FDA authority to approve safe and effective, more affordable biogeneric drugs","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,480000,0,0,2008-04-17T17:10:08-04:00
596627,5b0021e0-5508-4c4e-abbb-a9985d1ee02c,Q1,DOW LOHNES GOVERNMENT STRATEGIES LLC,316013,APOTEX CORP,2008,first_quarter,PHA,"H.R. 3700 Fair Medicaid Drug Payment Act of 2007, provisions related to regulation of generic drugs and consumer access; H.R. 1902 Protecting Consumer Access to Generic Drugs Act of 2007, all provisions related to generic drug consumer access; H.R. 3610 Food and Drug Import Safety Act of 2007, provisions related to drug safety; H.R. 5629 Pathway for Biosimilars Act, all provisions related to FDA licensure of biogeneric drugs","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2008-04-17T17:32:38-04:00
596710,ced0616e-b38e-422e-a190-ce2e2f7d639a,Q1,ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM,58534,ATRIUM HEALTH - FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM,2008,first_quarter,PHA,"HR 2606, HR 1376. Any language expanding the 340B drug discount rebate to inpatient pharmaceuticals.","Congressional Budget Office (CBO),HOUSE OF REPRESENTATIVES,SENATE",,160359,0,0,2008-04-17T17:46:52-04:00
596927,456b0cb1-9126-4068-85c8-dca99d44962b,Q1,"VAN NESS FELDMAN, LLP",39815,MCKESSON CORPORATION,2008,first_quarter,PHA,"S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007
H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007
S. 251, Pharmaceutical Market Access Act of 2007
S. 596, Safe Internet Pharmacy Act of 2007 S. 980, Online Pharmacy Consumer Protection Act of 2007
H.R. 971, Community Pharmacy Fairness Act of 2007
S. 885, Community Pharmacy Fairness Act of 2007
H.R. 3140, Saving Our Community Pharmacies Act of 2007
H.R. 3193, Access to Community Pharmacy Preservation Act of 2007
S. 1951, Fair Medicaid Drug Payment Act of 2007
H.R. 3700, Fair Medicaid Drug Payment Act of 2007
H.R. 780, Counterfeit Drug Prevention Act of 2007
S. 2085, Patient and Pharmacy Protection Act of 2007
S. 207, Combat Methamphetamine Enhancement Act of 2007","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2008-04-17T18:40:35-04:00
597121,34c4e9b2-468c-462b-9287-6ebc364da6ad,Q1,"CGCN GROUP, LLC",76992,BARR PHARMACEUTICALS INC (FORMERLY BARR LABORATORIES INC ),2008,first_quarter,PHA,"H.R.3161, S.1859, Funding for the Office of Generic Drugs, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act H.R.2900, S.1082, Food and Drug Administration Reform","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2008-04-17T21:44:46-04:00
597296,3cd09ce2-dfbd-4567-9f9b-8c2de0f31c7d,Q1,"ABELL, HENRY & ASSOCIATES, LLC",318378,EXPRESS SCRIPTS INCORPORATED,2008,first_quarter,PHA,DoD Pharmacy Issues,,,,0,0,2008-04-18T08:45:41-04:00
597346,085ed782-a174-4b31-ae98-1682326dd875,Q1,UNIVERSITY OF CONNECTICUT,39382,UNIVERSITY OF CONNECTICUT,2008,first_quarter,PHA,"Implementation of Prescription Drug User Fee Amendments 2007 (Public Law 110-85), Drug safety related issues.","Defense, Dept of (DOD),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,60000,0,0,2008-04-18T09:12:30-04:00
597989,2dd29d46-878c-4ae6-b15e-a1a9b9c8898e,Q1,FABIANI & COMPANY,72576,ALNYLAM PHARMACEUTICALS,2008,first_quarter,PHA,"S.1145 Patent Reform Act
Provisions relating to the apportionment of damages","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2008-04-18T10:42:40-04:00
598117,ba1f6ac8-90fd-493e-a2ff-ed31279a7376,Q1,KEVIN MCGUINESS PLLC,299811,FEDERATION OF AMERICAN HOSPITALS,2008,first_quarter,PHA,"The Community Pharmacy Fairness Act, HR 971/S. 2161","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2008-04-18T10:56:55-04:00
598131,4875a95f-ce20-46ef-98e1-d439dbc1302e,Q1,KEVIN MCGUINESS PLLC,299811,BARR LABS,2008,first_quarter,PHA,"Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics. S. 3818, HR 2795, entire legislation addressing changes to the patent process; other potential legislation to reform the patent process. S. 316, Preserve Access to Affordable Biologics, S. 623/HR 1032, Access to Life Saving Medicine Act.","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2008-04-18T10:59:05-04:00
598806,df250d56-0aae-49b0-bfa2-697906b59056,Q1,NATIONAL ASSOCIATION OF CHAIN DRUG STORES,26672,NATIONAL ASSOCIATION OF CHAIN DRUG STORES,2008,first_quarter,PHA,"See addendum. 1.S.242/H.R.380, the Pharmaceutical Market Access and Drug Safety Act of 2007, as related to provisions governing the importation of prescription drugs. 
2.S.251, the Pharmaceutical Market Access Act of 2007, all provisions governing the importation of prescription drugs.
3.S. 484, the Enhancing Drug Safety and Innovation Act of 2007, all provisions related to the safety of prescription medicines.
4.S. 604, the Military Health Care Protection Act, as related to provider participation in the Department of Defense TRICARE program.
5.S. 980, Online Pharmacy Consumer Protection Act of 2007, as related to the regulation of online pharmacies.
6.S. 1200, Indian Health Care Improvement Act Amendments of 2007, all provisions related to reducing fraud and abuse in the Medicare program.
7.S. 1276/H.R.2747, the Methamphetamine Production Prevention Act of 2007, as related to the distribution of legal substances used in the production of methamphetamine.
8.S. 1693, the Wired for Health Care Quality Act of 2007, as related to improving health information technology.
9.S. 1695, the Biologics Price Competition and Innovation Act of 2007, as related to the approval of generic biopharmaceuticals.
10.S. 1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007 as related to provider participation in the Medicare program.
11.S.1915, Electronic Prescription Drug Act of 2007, as related to the regulation of electronic prescribing of pharmaceuticals
12.S.1951/H.R.3700, Fair Medicaid Drug Payment Act of 2007, as related to Medicaid provider reimbursement.
13.S.1954, Pharmacy Access Improvement (PhAIm) Act of 2007, as related to access standards to pharmacies.
14.S.2013/H.R.3090, Patient and Pharmacy Protection Act of 2007, as related to prescription requirements in the Medicaid program.
15.S.2071, Combat Methamphetamine Enhancement Act of 2007, as related to the distribution of legal substances used in the production of methamphetamine.
16.S.2274, Dextromethorphan Abuse Reduction Act of 2007, as related to steps to prevent the abuse of dextromethorphan.
17.S.2408/H.R.4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007, as related to the regulation of electronic prescribing of pharmaceuticals.
18.H.R.976, Small Business Tax Relief Act of 2007, all provisions associated with work-related tax credits.
19.H.R. 970, the Dextromethorphan Distribution Act of 2007, as related to steps to prevent the abuse of dextromethorphan.
20.H.R. 971/S.855, the Community Pharmacy Fairness Act of 2007, as related to provider negotiations in the Medicare program.
21.H.R.1038/S.623, Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals.
22.H.R. 1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007, as related to provider reimbursement in the Medicare program
23.H.R.1585/S.1548, National Defense Authorization Act for Fiscal Year 2008, as related to retail pharmacy participation in the Department of Defense TRICARE program.
24.H.R.1845, the Medicare Durable Medical Equipment Access Act of 2007, as related to provider inclusion in the Medicare Part B program. 
25.H.R.1902, the Protecting Consumer Access to Generic Drugs Act of 2007, as related to the availability of generic pharmaceuticals.
26.H.R.2716, the Reducing Fraudulent and Imitation Drugs Act of 2007, as related to the safety of prescription drugs.
27.H.R. 2900, the Food and Drug Administration Amendments of 2007, all provisions related to prescription drug information and safety.
28.H.R.3109, the Dental Health Promotion Act of 2007, all provisions related to payment for health services.
29.H.R.3140, Saving Our Community Pharmacies Act of 2007, as related to Medicaid provider reimbursement.
30.H.R.3162, Children's Health and Medicare Protection Act of 2007, provisions related to health insurance in the Medicare program.
31.H.R.3193, Access to Community Pharmacy Preservation Act of 2007, as related to Medicaid provider reimbursement.
32.H.R.3580, Food and Drug Administration Amendments Act of 2007, all provisions related to prescription drug information and safety.
33.H.R.3610, Food and Drug Import Safety Act of 2007, provisions related to the safety of prescription drugs.
34.H.R.5268/S.2620, Temporary Increase of Medicaid FMAP, all provisions related to payments in the Medicaid program. 35.H.R.5480/S.2662, Medicare Funding Warning Response Act of 2008, all provisions related to provider access and payments in the Medicare program.
36.H.R.5491, Emilys Act, as related to the certification of pharmacy technicians.
37.H.R.5546, Credit Card Fair Fee Act of 2008, as related to fees associated with credit card purchase.
38.H.R.5613, Protecting the Medicaid Safety Net Act of 2008, all provisions related to provider participation in the Medicaid program.
39.H.R.5629, Pathway for Biosimilars Act, as related to the availability of generic pharmaceuticals.
40.H.Con.Res.312/S.Con.Res.70, Concurrent Resolution on the Budget for Fiscal Year 2009, all provisions related to healthcare providers and prescription drugs.","Centers For Medicare and Medicaid Services (CMS),Consumer Product Safety Commission (CPSC),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Executive Office of the President (EOP),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Labor, Dept of (DOL),Office of Natl Drug Control Policy (NDCP),Office of Personnel Management (OPM),President of the U.S.,SENATE",,370000,0,0,2008-04-18T11:54:18-04:00
598991,9737aa2d-3348-4b17-83e8-da07b2b125c4,Q1,THE DUBERSTEIN GROUP INC.,12675,AMERICA'S HEALTH INSURANCE PLANS,2008,first_quarter,PHA,"Pharmacy issues - S 623, Access to Life-Saving Medicine Act; HR 1038, Access to Life-Saving Medicine Act; S 1505, Affordable Biologics for Consumers Act; S 316,  Preserve Access to Affordable Generics Act; S 1695, Biologics Price Competition and Innovation Act of 2007; HR 971, Community Pharmacy Fairness Act of 2007; S 885, Community Pharmacy Fairness Act of 2007; S 980, Online Pharmacy Consumer Protection Act of 2007; HR 5629, Pathway for Biosimilars Act.","HOUSE OF REPRESENTATIVES,SENATE,White House Office",100000,,0,0,2008-04-18T12:13:55-04:00
599271,2c29674f-21f5-4a5f-bc5a-9a52ce3eef4d,Q1,"TARPLIN, DOWNS & YOUNG, LLC",304736,WYETH,2008,first_quarter,PHA,"*see addendum page FDAAA Implementation

Biosimilars
    H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007
    S. 623/H.R.1038 - Access to Life- Saving Medicine Act, Follow-On Biologics
    S. 1695 - Biologics Price Competition and Innovation Act of 2007
    S. 1505 - Affordable Biologics for  Consumers Act
    H.R. 5629, the ""Pathway for Biosimilars Act.""

Import Safety
    H.R. 3610 - Food and Drug Import Safety Act of 2007

***, no specific bill(s), Biosimilars, Drug Safety, Prescription Drug Importation, Import Safety","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",40000,,0,0,2008-04-18T12:56:15-04:00
599278,a52637ca-7def-480e-bd77-e836247dd6e5,1T,TROUTMAN STATEGIES,81511,BRANDED PHARMACEUTICAL ASSOCIATION,2008,first_quarter,PHA,Seek legislative and regulatory support for Desi drugs,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,1,2008-04-18T12:58:11-04:00
599309,3136aa67-b5c9-41fc-9874-bfd0781128be,Q1,UNIVERSITY OF ILLINOIS,39427,UNIVERSITY OF ILLINOIS,2008,first_quarter,PHA,"H.R. 4054 - Prevention Through Affordable Access Act, Sec. 2, all provisions relating to restoring and protecting access to discount drug prices for university-based and safety-net clinics; (a), all provisions relating to restoring normal pricing. S. 2347 - Prevention Through Affordable Access Act, Sec. 2, all provisions relating to restoring and protecting access to discount drug prices for university-based and safety-net clinics.","Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Federal Aviation Administration (FAA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),Natl Science Foundation (NSF),Patent & Trademark Office (PTO),SENATE,State, Dept of (DOS)",,60000,0,0,2008-04-18T13:01:31-04:00
599432,07f3f6de-6c93-4ada-8d51-4be453da4e53,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,SUNOVION PHARMACEUTICALS INC (FORMERLY SEPRACOR INC ),2008,first_quarter,PHA,No specific legislation or bills introduced at this time.  Medicare reimbursement issues.,,20000,,0,0,2008-04-18T13:18:38-04:00
599579,523a48bb-2217-42f1-a86c-a09d254aef30,1T,"PARRY, ROMANI, DECONCINI & SYMMS",30792,SIDLEY AUSTIN LLP (FOR SEPRACOR),2008,first_quarter,PHA,Medicare reimbursement issues.  Ensure appropriate reimbursement for branded drugs.  No legislation introduced yet.,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,1,2008-04-18T13:34:19-04:00
600184,55a62901-d25a-402b-a269-b2b2adc7c267,Q1,DUANE MORRIS GOVERNMENT AFFAIRS,49657,CB DISTRIBUTORS INC,2008,first_quarter,PHA,Regulation of over-the-counter asthma-cough medicines.,"Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2008-04-18T14:25:08-04:00
600343,1246f9b1-7eca-4a9b-8893-836c4cb72d61,Q1,AVENUE SOLUTIONS,72111,EXPRESS SCRIPTS INC,2008,first_quarter,PHA,"HR 971 Community Pharmacy Fairness Act of 2007 
HR 2970  Pharmacy Benefit Manager Transparency Act of 2007 
HR 3140 Saving Our Community Pharmacies Act of 2007
HR 3090 Patient and Pharmacy Protection Act of 2007 HR 3193 Access to Community Pharmacy Preservation Act of 2007 
S 885 Community Pharmacy Fairness Act of 2007 
S 980 Online Pharmacy Consumer Protection Act of 2007 
S 1827 Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007 
S 1954 Pharmacy Access Improvement (PhAIm) Act of 2007 
S 2013 Patient and Pharmacy Protection Act of 2007 
S 2085 Patient and Pharmacy Protection Act of 2007 
S 2161 Community Pharmacy Fairness Act of 2007
Internet Pharmacies
Off-Label Use of Prescription Drugs.","HOUSE OF REPRESENTATIVES,SENATE",75000,,0,0,2008-04-18T14:39:36-04:00
600351,ee3d6ef4-8c1b-49e6-85e6-0479bd55751f,Q1,"BLUE CROSS AND BLUE SHIELD OF KANSAS, INC.",323876,BLUE CROSS AND BLUE SHIELD OF KANSAS INC,2008,first_quarter,PHA,E-prescribing,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE,White House Office",,,0,0,2008-04-18T14:41:04-04:00
600386,c0f2eb6f-e116-40c1-9dd8-4d88aced2da2,Q1,ANIMAL HEALTH INSTITUTE,4037,ANIMAL HEALTH INSTITUTE,2008,first_quarter,PHA,"Animal drug and biologics regulation and approval process, Antibiotic Resistance; Animal Drug User Fee Act; HR 962 & S 549, Preservation of Antibiotics for Medical Treat Act of 2007; HR 2419, Farm, Nutrition, and Bioenergy Act of 2007; S 2302, Food And Energy Security Act of 2007; S 2313, Strategies to Address Antimicrobial Resistance Act; HR 3697, to Amend the Public Health Service Act to Address Antimicrobial Resistance; HR 2900,","Agriculture, Dept of (USDA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE",,30000,0,0,2008-04-18T14:44:12-04:00
600495,a453bd82-7756-40be-a9be-c2abfbd9be81,Q1,HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA),28776,HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA),2008,first_quarter,PHA,"Importation of prescription drugs (H.R. 3161, S. 1644)
Rx Pedigree
Methaphetamine/Pseudoephedrine Regulation (S. 2071)
Internet Pharmacy (S. 980)","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,165000,0,0,2008-04-18T14:55:03-04:00
600574,0c0915db-80bc-4c14-b81d-4af66a2a1716,Q1,AVENUE SOLUTIONS,72111,BLUE CROSS BLUE SHIELD ASSOCIATION,2008,first_quarter,PHA,E-prescribing,,81000,,0,0,2008-04-18T15:02:28-04:00
600747,9e72c616-8cc5-449d-9326-41db0dc8cecc,Q1,KRIEG DEVAULT LLP,21905,DR ERICH HUGO CERNY,2008,first_quarter,PHA,Patent extension,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2008-04-18T15:13:36-04:00
600890,36d4b292-9dba-4581-a23d-6a11474c7419,Q1,SHIRE PHARMACEUTICALS LLC,323477,SHIRE PHARMACEUTICALS LLC,2008,first_quarter,PHA,"Biosimilars legislation; orphan provisions; ADHD

Agency for Healthcare Research & Quality (Line 17)","HOUSE OF REPRESENTATIVES,SENATE",,171000,0,0,2008-04-18T15:23:08-04:00